EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Paradoxical Modulation of STN β‐Band Activity with Medication Compared to Deep Brain Stimulation

Meghan E Hill iD, Luke A Johnson iD, Jing Wang, David Escobar Sanabria, Rémi Patriat, Scott E Cooper, Michael C Park, Noam Harel, Jerrold L Vitek, Joshua E Aman

Movement Disorders · 2024

DOI: 10.1002/mds.29634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2024. Verfasst von Meghan E Hill und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Subthalamic Nucleus, Deep Brain Stimulation, Parkinson Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIBIB NIH HHS, NCATS NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Excessive subthalamic nucleus (STN) β‐band (13–35 Hz) synchronized oscillations has garnered interest as a biomarker for characterizing disease state and developing adaptive stimulation systems for Parkinson's disease (PD).

Objectives

To report on a patient with abnormal treatment‐responsive modulation in the β‐band.

Methods

We examined STN local field potentials from an externalized deep brain stimulation (DBS) lead while assessing PD motor signs in four conditions (OFF, MEDS, DBS, and MEDS+DBS).

Results

The patient presented here exhibited a paradoxical increase in β power following administration of levodopa and pramipexole (MEDS), but an attenuation in β power during DBS and MEDS+DBS despite clinical improvement of 50% or greater under all three therapeutic conditions.

Conclusions

This case highlights the need for further study on the role of β oscillations in the pathophysiology of PD and the importance of personalized approaches to the development of β or other biomarker‐based DBS closed loop algorithms. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subthalamic NucleusDeep Brain StimulationParkinson DiseaseHumansLevodopaBiomarkers

Stichwörter der Autor:innen

Parkinson's diseasedeep brain stimulationlevodopalocal field potentialsβ-band activity

Substanzen

LevodopaBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Radiology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Meghan E Hill, Luke A Johnson

Förderung

  • NIBIB NIH HHS
  • NCATS NIH HHS
  • NINDS NIH HHS
  • NCI NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Hill, M. E., Johnson, L. A., Wang, J., Escobar Sanabria, D., Patriat, R., Cooper, S. E., Park, M. C., Harel, N., Vitek, J. L., & Aman, J. E. (2024). Paradoxical Modulation of STN β‐Band Activity with Medication Compared to Deep Brain Stimulation. Movement Disorders. https://doi.org/10.1002/mds.29634

Vancouver

Hill ME, Johnson LA, Wang J, Escobar Sanabria D, Patriat R, Cooper SE, et al. Paradoxical Modulation of STN β‐Band Activity with Medication Compared to Deep Brain Stimulation. Movement Disorders. 2024. doi:10.1002/mds.29634

BibTeX
@article{Hill2024,
  author = {Hill, Meghan E and Johnson, Luke A and Wang, Jing and Escobar Sanabria, David and Patriat, Rémi and Cooper, Scott E and Park, Michael C and Harel, Noam and Vitek, Jerrold L and Aman, Joshua E},
  title = {Paradoxical Modulation of STN β‐Band Activity with Medication Compared to Deep Brain Stimulation},
  journal = {Movement Disorders},
  year = {2024},
  doi = {10.1002/mds.29634}
}
Kostenlos starten →